Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

First-of-its-kind Clinical Trial Monitoring Service Launched for Cancer Patients

Specimatch, the first continual clinical trial monitoring service announces the launch of its web-based software service for cancer patients. Users can easily connect to clinical trials personally matched to the patient’s genetic and clinical profiles through Specimatch.com.

This software is a solution for patients and oncologists to tap into a complex landscape of breakthrough treatments with both accuracy and simplicity.

It alleviates the gaps in care by putting the power of precision medicine in the hands of patients and the doctors with whom they partner in the fight against cancer.

Using Specimatch ‘continual 24/7 monitoring’, it would be easy to identify matching trials in real time, based on a user-completed clinical and genetic profile. Cancer patients will meet their match and survival rates will enhance.

Clinical trials are the key drivers in bringing cancer breakthroughs to market, yet 75 percent of investigators fail to enroll the targeted amount of patients per trial despite hundreds of millions of dollars in spending per trial.

Approximately 85 percent of U.S. Cancer patients lack access to these opportunities although trials offer first access to cutting-edge precision treatments. And only 3 percent are successfully placed into trials.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024